Novavax Inc
(NVAX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 30,659 | 20,915 | 22,076 | 14,688 | 343 |
| Cost of Goods | N/A | N/A | 14,692 | 7,003 | N/A |
| Gross Profit | 30,659 | 20,915 | 7,384 | 7,685 | 343 |
| Operating Expenses | 114,350 | 73,349 | 37,741 | 29,267 | 38,837 |
| Operating Income | -83,691 | -52,434 | -29,665 | -21,579 | -38,494 |
| Interest Expense | 157 | 160 | 32 | 9 | 9 |
| Other Income | 901 | 636 | 1,190 | 2,636 | 2,345 |
| Pre-tax Income | -82,947 | -51,958 | -28,507 | -18,952 | -36,158 |
| Income Tax | N/A | 25 | 0 | 412 | -450 |
| Net Income Continuous | -82,947 | -51,983 | -28,507 | -19,364 | -35,708 |
| Net Income | $-82,947 | $-51,983 | $-28,507 | $-19,364 | $-35,708 |
| EPS Basic Total Ops | -7.40 | -6.20 | -4.40 | -3.40 | -6.80 |
| EPS Basic Continuous Ops | -7.35 | -6.13 | -4.33 | -3.41 | -6.82 |
| EPS Diluted Total Ops | -7.40 | -6.20 | -4.40 | -3.40 | -6.80 |
| EPS Diluted Continuous Ops | -7.35 | -6.13 | -4.33 | -3.41 | -6.82 |
| EBITDA(a) | $-78,852 | $-49,336 | $-28,017 | $-19,649 | $-36,875 |